350965 <common-name>5-[4-(2-hydroxyethyl)piperazine-1-carbonyl]-5,9-dimethyl-19-propan-2-yl-15-oxapentacyclo[10.5.2.01,10.04,9.013,17]nonadec-18-ene-14,16-dione</common-name> <description>5-[4-(2-hydroxyethyl)piperazine-1-carbonyl]-5,9-dimethyl-19-propan-2-yl-15-oxapentacyclo[10.5.2.01,10.04,9.013,17]nonadec-18-ene-14,16-dione is a chemical compound with the formula C30H44N2O5. With an average molecular weight of 512.70 g/mol, 5-[4-(2-hydroxyethyl)piperazine-1-carbonyl]-5,9-dimethyl-19-propan-2-yl-15-oxapentacyclo[10.5.2.01,10.04,9.013,17]nonadec-18-ene-14,16-dione is a heavy molecule.</description> <cas>53003-82-0</cas> <pubchem-id>3040838</pubchem-id> <chemical-formula>C30H44N2O5</chemical-formula> <weight>512.7</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-31T16:22:10Z</created-at> <updated-at type="dateTime">2026-08-31T16:22:10Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CC(C)C1=CC23CCC4C(C2CC1C5C3C(=O)OC5=O)(CCCC4(C)C(=O)N6CCN(CC6)CCO)C</moldb-smiles> <moldb-formula>C30H44N2O5</moldb-formula> <moldb-inchi>InChI=1S/C30H44N2O5/c1-18(2)20-17-30-9-6-21-28(3,22(30)16-19(20)23-24(30)26(35)37-25(23)34)7-5-8-29(21,4)27(36)32-12-10-31(11-13-32)14-15-33/h17-19,21-24,33H,5-16H2,1-4H3</moldb-inchi> <moldb-inchikey>XJQVMDWQJUSDTN-UHFFFAOYSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">512.3250225</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>3.5</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM346858</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>5-[4-(2-hydroxyethyl)piperazine-1-carbonyl]-5,9-dimethyl-19-propan-2-yl-15-oxapentacyclo[10.5.2.01,10.04,9.013,17]nonadec-18-ene-14,16-dione</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Lipids and lipid-like molecules</superklass> <klass>Prenol lipids</klass> <subklass>Diterpenoids</subklass> <paper-count type="integer" nil="true"/> <sync-id>CED0301269</sync-id> <structure-inchikey>XJQVMDWQJUSDTN-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>4000000000000100002080000000020000000000000000000004000300800000001000100000202000000008000000000000000000000000010000420200000000000000000004003000020000000000082080000000000000000000000000008000000001000000000000000000004000000002010400000000000000000010080000004800000000000000000400400020000400000000400000000000002010880000000400000000000008800000000000000400400004a000400000000000000000000104000800010000800080000000000000000000000000000000010000200000000000000040000000000400000000000000000000804000080000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAlAAAAKgAAAIABBgBgAAAAAQMGAGAAAAAD AQYAYAAAAAEDBgAoAAAAAwQGAGgAAAADAwEGACAAAAAEBgBgAAAAAgIGAGAA AAACAgYAYAAAAAMBBgAgAAAABAYAYAAAAAMBBgBgAAAAAgIGAGAAAAADAQYA YAAAAAMBBgBgAAAAAwEGACgAAAADBAgAKAAAAAMCCAAoAAAAAwIGACgAAAAD BAgAKAAAAAMCBgBgAAAAAgIGAGAAAAACAgYAYAAAAAICBgAgAAAABAYAYAAA AAEDBgAoAAAAAwQIACgAAAADAgcAKAAAAAMDBgBgAAAAAgIGAGAAAAACAgcA IAAAAAMGAGAAAAACAgYAYAAAAAICBgBgAAAAAgIGAGAAAAACAggAYAAAAAEB BgBgAAAAAQMLAAEAAQIAAQMAAwQIAgQFAAUGAAYHAAcIAAgJAAkKAAoLAAsM AAwNAA0OAA4PAA8QKAIPESAREiASEygCCRQAFBUAFRYAFhcAFxgAFxkAGRoo AhkbIBscABwdAB0eAB4fAB8gAB4hACEiACIjAAkkAAwDAAoFAA4FABcIABIN ACAbAEIHAAAABQ8ODRIRBgMMCwoFBAYDDA0OBQQGBgcICQoFBhQVFhcICQYc HR4fIBsGCwwNDgUKFwQAAAAAAAAAFg== </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:48:55Z</structure-indexed-at> </compound>